In re Seaborg

328 F.2d 998, 51 C.C.P.A. 1109, 140 U.S.P.Q. (BNA) 662, 1964 CCPA LEXIS 446
CourtUnited States Customs Court
DecidedMarch 19, 1964
DocketNo. 7061
StatusPublished
Cited by8 cases

This text of 328 F.2d 998 (In re Seaborg) is published on Counsel Stack Legal Research, covering United States Customs Court primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
In re Seaborg, 328 F.2d 998, 51 C.C.P.A. 1109, 140 U.S.P.Q. (BNA) 662, 1964 CCPA LEXIS 446 (cusc 1964).

Opinion

Smith, Judge,

delivered the opinion of the court:

The application1 and the claims in issue relate to a new transuranic [1110]*1110element having atomic number 95,2 now known as Americium (Am) ,• to isotopes thereof, and to methods of producing and purifying said element and compositions thereof. Two isotopes of Americium are disclosed, Americium 241 and 242. Two general methods of synthesizing element 95 are set forth, namely (1) bombardment of plutonium with deuterons or neutrons; and (2) in a neutronic reactor operated at á relatively high power level (about 200 kw) for an extended period of time (approximately 100 days). A suitable reactor is said to be that described in Fermi et al. application Serial No. 568,904, filed December 19,1944, which is now U.S. Patent No. 2,708,656.

The claims in issue read simply:

T. Element 95.

2. The isotope of element 95 having the mass number 241. There is but a single ground of rejection involving the above claims, i.e., unpatentability over the Fermi et al. patent, for the reason that element 95 must be inherently produced in the operation of the reactor disclosed therein.

The Fermi et al.; patent discloses several nuclear reactors. The patent does not mention elements 95 and 96. The claims in issue were first rejected on the Fermi patent in the examiner’s letter of May 25,1955. The specific basis for the examiner’s rejection on Fermi was the exemplary statement of reactor operation contained in the patent, namely:

After operation of the reactor for a sufficient length of time for an amount of 94238 to be created sufficient for chemical separation, such as, for example, 100 days at 500 kilowatts, the reactor is shut down by inserting the control rod fully into the reactor. After about one-half hour’s wait, during which all delayed neutron emission will have ceased and the more highly radioactive materials decayed sufficiently, the reactor may be unloaded.
. * * * * * * *
* ⅛ * After 100 days’ operation the aging period may be about 30 days.

Appellant, however, asserts in his brief:

* * * The statements are exemplary only. If, however, the statements are accepted on the basis of the Smyth Report as factual, the maximum amount of americium 241 that could have been produced in the reactor operated for 100 days at 500 kilowatts power can be calculated to be 6.15 x 10"° gram. Thus the reactor could have produced no more than one billionth [sic] [3] of a gram •of americium-241, and this one billionth of a gram would have been distributed throughout forty tons of intensely radioactive uranium reactor fuel. This amount of an unknown, uneoncentrated isotope, if present, would have been .undetectable. * * *

[1111]*1111The solicitor has taken no issue with appellant’s assertion that the Fermi reactor in the exemplary operation relied on by the examiner “could have produced no more than one billionth of a gram of americium-241, and this one billionth of a gram would have been distributed throughout forty tons of intensely radioactive uranium reactor fuel.’’ In fact, the solicitor states in his brief:

* * * The facts are relatively simple and. not actually in dispute. The rejection is not based upon a finding that the patent expressly discloses the formation of the claimed element, but rather upon the conclusion reached that that product is inherently produced in the operation of the Fermi reactor. This conclusion is based upon a comparison of the method disclosed in appellant’s application for producing the product with the method of operation described in the patent. Such comparison has been sanctioned by this Court in In re Wiegand et al 87 COPA 1101,182 F2d 683.

The position of the Patent Office is further stated in the solicitor’s as follows:

* * Since the products produced in a neutronic reactor depend upon the manner of operation, and appellant does not and cannot really challenge the findings of similarity between appellant’s process and Fermi’s process, the inference that the claimed product is inherently produced is reasonable and logical. That finding merits this Court’s approval, as in In re Wiegand et al, supra.

The issue here arises by application of what both the appellant and the solicitor term the “inherency doctrine”, which, as we understand it, is a Patent Office doctrine which infers a lack of novelty in a product under 35 U.S.C. 101 if a comparable process for making the product- is found to exist in the art. When so stated and applied to the facts here this doctrine establishes a broader basis for refusing a patent than is required by the courts in finding anticipation of an issued patent. It goes beyond the rule as stated by Judge Learned Hand in Dewey & Almy Chemical Co. v. Mimex Co., 124 F. 2d 986, 989, 52 USPQ 138 (2d Cir. 1942) :

No doctrine of the patent law is better established .than that a prior patent or other publication to be an anticipation must bear within its four corners adequate directions for the practice of the patent invalidated. If the earlier disclosure offers no more than a starting point for further experiments, if its teaching will sometimes succeed and sometimes fail, if it does not inform the art without more how to practice the new invention, it has not correspondingly enriched the store of common knowledge, and it is not an anticipation.

The “inherency doctrine” we are here urged to apply appears to have been extrapolated by the Patent Office from language found in the Wiegand case. Whatever validity the general language used may have had in the field of carbon black production, its validity is much more doubtful when applied as it has been in the present case. The Wiegand case involved claims to a furnace carbon black as a product. They were rejected on references showing the production of carbon [1112]*1112black by furnace processes and on a prior product patent covering the furnace carbon black produced by one of the furnaces. This court affirmed the action of the board and summarized the position of the examiner and the board in the following language (37 CCPA at 1105):

Both the Primary Examiner and the board were of the opinion that Brown-lee’s patent product, Patent No. 1,920,352, would inherently possess the same properties as those embraced in the product defined in appellants’ claims because of the similarity of the process of appellants to that of Brownlee, Patent No. 1,909,163.

The court recognized the difficulties in such cases and stated (37 CCPA 1106) :

The situation presented here is somewhat unusual and not free from perplexity, because its determination is dependent to such a great extent upon inferences rather than upon definitely established facts.

In concluding its opinion we think the court stated the problem in the Wiegand case as being based, at least in good part, on the indefinite nature of the claimed distinctions, i.e., the particle size of the carbon black. Thus the court stated (37 CCPA 1108) :

Free access — add to your briefcase to read the full text and ask questions with AI

Related

Smithkline Beecham Corp. v. Apotex Corp.
403 F.3d 1331 (Federal Circuit, 2005)
Schering Corp. v. Geneva Pharmaceuticals, Inc.
339 F.3d 1373 (Federal Circuit, 2003)
Schering Corporation v. Geneva Pharmaceuticals
339 F.3d 1373 (Federal Circuit, 2003)
In re Bergy
596 F.2d 952 (Customs and Patent Appeals, 1979)
Application of Sune Bergstrom and Jan Sjovall
427 F.2d 1394 (Customs and Patent Appeals, 1970)

Cite This Page — Counsel Stack

Bluebook (online)
328 F.2d 998, 51 C.C.P.A. 1109, 140 U.S.P.Q. (BNA) 662, 1964 CCPA LEXIS 446, Counsel Stack Legal Research, https://law.counselstack.com/opinion/in-re-seaborg-cusc-1964.